These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15956015)

  • 1. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal effects of drugs used in the treatment of portal hypertension.
    Henriksen JH; Ring-Larsen H
    Hepatology; 1993 Sep; 18(3):688-95. PubMed ID: 8103034
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?].
    Shestakova MV
    Ter Arkh; 2001; 73(6):64-6. PubMed ID: 11521527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium antagonists: current and future applications based on new evidence. Renal protective action of calcium channel blockers].
    Kimura G
    Clin Calcium; 2010 Jan; 20(1):94-9. PubMed ID: 20048440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 12. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension?
    Adelman A
    J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selective microproteinuria as a marker of incipient renal impairment in patients with hypertension].
    Eremina IuN; Leonova MV; Belousov IuB; Tarasov AV
    Kardiologiia; 2004; 44(10):71-7. PubMed ID: 15477795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal consequences of antihypertensive therapy.
    Eknoyan G; Suki WN
    Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of hypertension in upheaval?].
    Zidek W; Paul M
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension.
    Cuddy ML
    J Pract Nurs; 2006; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
    Coca A
    An Med Interna; 2003 Jun; 20(6):279-81. PubMed ID: 12848596
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy as first-line treatment for arterial hypertension].
    Glezer MG
    Ter Arkh; 2005; 77(10):93-6. PubMed ID: 16320697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.